====== COVID-19 Therapeutics Task Force ======

The **COVID-19 Therapeutics Task Force** was a Canadian public-private advisory body convened by [[Innovation, Science and Economic Development Canada]] (ISED).((Innovation, Science and Economic Development Canada. (2022, March 10). //COVID-19 Therapeutics Task Force.// Government of Canada. http://archive.today/2023.04.27-230206/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force))

===== History =====

[[Navdeep Bains]], Minister of Innovation, Science and Industry, announced the membership of the COVID-19 Therapeutics Task Force on August 5, 2020.((Jagric, A., Roy, C., Innovation, Science and Economic Development Canada, & Public Services and Procurement Canada. (2020, August 5). //Government of Canada announces major steps in treating and preventing COVID-19 through vaccines and therapies.// Government of Canada. http://archive.today/2022.12.16-235932/https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html)) Bains also announced the membership of the [[COVID-19 Vaccine Task Force]].
===== Members =====

^  Members  ^^^
^ Name  ^ Position  ^ Affiliation(s)  ^
| [[Nancy Harrison]]  | Co-chair  | [[Life Sciences British Columbia]], [[Ventures West]], [[pharmaceutical_companies:MSI Methylation Sciences]], [[Creative Destruction Lab]], [[adMare BioInnovations]], [[Digital Technology Supercluster]], [[Genome British Columbia]], [[pharmaceutical_companies:Knight Therapeutics]]  |
| [[Cédric Bisson]]  | Co-chair  | [[Teralys Capital]], [[iNovia Capital]], [[McKinsey & Company]], [[Montreal InVivo]], [[Grand Challenges Canada]], [[Procure]]  |
| [[Maha Katabi]]  | Member  | [[Sofinnova]], [[pharmaceutical_companies:Amplyx Pharmaceuticals]], [[pharmaceutical_companies:Northsea Therapeutics]], [[Oxalis Capital]], [[Sectoral Asset Management]], [[Ventures West Management]], [[T2C2 Capital]], [[Exactis Innovation]]  |
| [[Gordon McCauley]]  | Member  | [[adMare BioInnovations]], [[Viable Healthworks]], [[pharmaceutical_companies:Allon Therapeutics]], [[NDI Cpaital]], [[BIOTECanada]], [[CGen]], [[Life Sciences British Columbia]], [[Biotechnology Innovation Organization]] (BIO), [[Acetech]], [[Toronto Rehabilitation Institute]], [[Toronto Rehab Foundation]]  |
| [[Parimal Nathwani]]  | Member  | [[Toronto Innovation Acceleration Partners]] (TIAP), [[MaRS Discovery District]], [[UBC University Industry Liaison Office]] (UILO), [[TRIUMF Innovations]], [[pharmaceutical_companies:Zucara Therapeutics]], [[pharmaceutical_companies:Vasomune Therapeutics]], [[pharmaceutical_companies:Encycle Therapeutics]]  |
| [[Ali Tehrani]]  | Member  | [[pharmaceutical_companies:Zymeworks]], [[Student Biotechnology Network]] (SBN), [[Consortium de recherche biopharmaceutique]] (CQDM), [[Life Sciences British Columbia]], [[Mitacs]], [[BIOTECanada]], [[Premier's Technology Council]], [[pharmaceutical_companies:Creatus Biosciences]]  |
| [[Youla Tsantrizos]]  | Member  | [[McGill University]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Centre de recherche en biologie structurale]] (CRBS), [[Canadian Society for Chemistry]], [[Natural Sciences and Engineering Research Council of Canada]] (NSERC), [[Canadian Institutes of Health Research]] (CIHR), [[Ontario Institute for Cancer Research]] (OICR)  |
^  Advisors  ^^^
| [[Lisa Barrett]]  | Advisor  | [[Dalhousie University]], [[Senescence Aging Infection & Immunity Lab]] (SAIL), [[National Institute of Allergy and Infectious Diseases]] (NIAID)  |
| [[Marceline Côté]]  | Advisor  | [[University of Ottawa]]  |
| [[Eleanor Fish]]  | Advisor  | [[University of Toronto]], [[University Health Network]] (UHN)  |
| [[Matthias Götte]]  | Advisor  | [[Li Ka Shing Institute of Virology]], [[McGill University]]  |
| [[François Jean]]  | Advisor  | [[Facility for Infectious Disease and Epidemic Research]] (FINDER)  |
| [[Samira Mubareka]]  | Advisor  | [[Sunnybrook Health Sciences Centre]], [[University of Toronto]], [[Centre for Research Expertise in Occupational Disease]] (CREOD), [[Canadian COVID-19 Genomics Network]] (CanCOGen), [[Genome Canada]], [[Ontario's COVID-19 Genomics Rapid Response Coalition]] (ONCoV), [[Ontario Academic Health Sciences SARS-CoV-2 Sequencing Network]] (ONS2), [[Sunnybrook Translational Research Group for Emerging Respiratory Viruses]] (SERV)  |
| [[Pamela Ohashi]]  | Advisor  | [[Princess Margaret Cancer Centre]], [[University of Toronto]], [[American Association for Cancer Research]] (AACR), [[Society for Immunotherapy of Cancer]] (SITC), [[Royal Society of Canada]] (RSC)  |
| [[James Russell]]  | Advisor  | [[University of British Columbia]] (UBC), [[Centre for Heart Lung Innovation]] (HLI), [[Sirius Genomics]], [[pharmaceutical_companies:Cyon Therapeutics]], [[St. Paul's Hospital]]  |
| [[Makeda Semret]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[Joint Programming Initiative on Antimicrobial Resistance]] (JPIAMR), [[AAU-McGill Partnership for Infectious Diseases]] (AMP-ID)  |
| [[Don Sheppard]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[McGill Interdisciplinary Initiative in Infection and Immunity]] (MI4)  |
| [[Don Vinh]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[Canadian Glycomics Network]] (GlycoNet), [[Association of Medical Microbiology and Infectious Disease Canada]] (AMMI), [[Clinical Immunology Society]] (CIS), [[Comité consultatif québécois pour les maladies rares]], [[MUHC COVID-19 Biobank]], [[COVID-19 and Cancer Consortium]] (CCC19), [[COVID Human Genetic Effort]] (CHGE)  |

===== External links =====

  * [[http://covidtruthinitiative.ca/Organizations/COVID-19-Therapeutics-Task-Force|COVID Truth Initiative]]